BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 26846848)

  • 1. PPARα (Peroxisome Proliferator-activated Receptor α) Activation Reduces Hepatic CEACAM1 Protein Expression to Regulate Fatty Acid Oxidation during Fasting-refeeding Transition.
    Ramakrishnan SK; Khuder SS; Al-Share QY; Russo L; Abdallah SL; Patel PR; Heinrich G; Muturi HT; Mopidevi BR; Oyarce AM; Shah YM; Sanchez ER; Najjar SM
    J Biol Chem; 2016 Apr; 291(15):8121-9. PubMed ID: 26846848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate Decreases Insulin Clearance and Insulin Secretion to Maintain Insulin Sensitivity.
    Ramakrishnan SK; Russo L; Ghanem SS; Patel PR; Oyarce AM; Heinrich G; Najjar SM
    J Biol Chem; 2016 Nov; 291(46):23915-23924. PubMed ID: 27662905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor alpha transcriptional up-regulation of fatty acid oxidation.
    Gremlich S; Nolan C; Roduit R; Burcelin R; Peyot ML; Delghingaro-Augusto V; Desvergne B; Michalik L; Prentki M; Wahli W
    Endocrinology; 2005 Jan; 146(1):375-82. PubMed ID: 15459119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.
    Sugden MC; Bulmer K; Gibbons GF; Knight BL; Holness MJ
    Biochem J; 2002 Jun; 364(Pt 2):361-8. PubMed ID: 12023878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.
    Hashimoto T; Cook WS; Qi C; Yeldandi AV; Reddy JK; Rao MS
    J Biol Chem; 2000 Sep; 275(37):28918-28. PubMed ID: 10844002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalpha.
    Danno H; Ishii KA; Nakagawa Y; Mikami M; Yamamoto T; Yabe S; Furusawa M; Kumadaki S; Watanabe K; Shimizu H; Matsuzaka T; Kobayashi K; Takahashi A; Yatoh S; Suzuki H; Yamada N; Shimano H
    Biochem Biophys Res Commun; 2010 Jan; 391(2):1222-7. PubMed ID: 20006574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression.
    Patsouris D; Reddy JK; Müller M; Kersten S
    Endocrinology; 2006 Mar; 147(3):1508-16. PubMed ID: 16357043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic PGC-1beta overexpression induces combined hyperlipidemia and modulates the response to PPARalpha activation.
    Lelliott CJ; Ljungberg A; Ahnmark A; William-Olsson L; Ekroos K; Elmgren A; Arnerup G; Shoulders CC; Oscarsson J; Lindén D
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2707-13. PubMed ID: 17932310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance.
    Al-Share QY; DeAngelis AM; Lester SG; Bowman TA; Ramakrishnan SK; Abdallah SL; Russo L; Patel PR; Kaw MK; Raphael CK; Kim AJ; Heinrich G; Lee AD; Kim JK; Kulkarni RN; Philbrick WM; Najjar SM
    Diabetes; 2015 Aug; 64(8):2780-90. PubMed ID: 25972571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate, a peroxisome proliferator-activated receptor α ligand, prevents abnormal liver function induced by a fasting-refeeding process.
    Lee JN; Dutta RK; Kim SG; Lim JY; Kim SJ; Choe SK; Yoo KW; Song SR; Park DS; So HS; Park R
    Biochem Biophys Res Commun; 2013 Dec; 442(1-2):22-7. PubMed ID: 24211584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal.
    El Kebbaj Z; Andreoletti P; Mountassif D; Kabine M; Schohn H; Dauça M; Latruffe N; El Kebbaj MS; Cherkaoui-Malki M
    Endocrinology; 2009 Mar; 150(3):1192-201. PubMed ID: 18948393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-alpha-dependent.
    Landrier JF; Thomas C; Grober J; Duez H; Percevault F; Souidi M; Linard C; Staels B; Besnard P
    J Biol Chem; 2004 Oct; 279(44):45512-8. PubMed ID: 15337740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor {alpha} is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db Mice.
    Im SS; Kim MY; Kwon SK; Kim TH; Bae JS; Kim H; Kim KS; Oh GT; Ahn YH
    J Biol Chem; 2011 Jan; 286(2):1157-64. PubMed ID: 21081500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia via ERK Signaling Inhibits Hepatic PPARα to Promote Fatty Liver.
    Mooli RGR; Rodriguez J; Takahashi S; Solanki S; Gonzalez FJ; Ramakrishnan SK; Shah YM
    Cell Mol Gastroenterol Hepatol; 2021; 12(2):585-597. PubMed ID: 33798787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
    Goetzman ES; Tian L; Wood PA
    Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of overlapping genes by fasting and a peroxisome proliferator in pigs: evidence of functional PPARalpha in nonproliferating species.
    Cheon Y; Nara TY; Band MR; Beever JE; Wallig MA; Nakamura MT
    Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1525-35. PubMed ID: 15650118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence against the peroxisome proliferator-activated receptor alpha (PPARalpha) as the mediator for polyunsaturated fatty acid suppression of hepatic L-pyruvate kinase gene transcription.
    Pan DA; Mater MK; Thelen AP; Peters JM; Gonzalez FJ; Jump DB
    J Lipid Res; 2000 May; 41(5):742-51. PubMed ID: 10787435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.